Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ARIAD shares rise on EU review of potential cancer drug
ARIAD shares rise on EU review of potential cancer drug
ARIAD shares rise on EU review of potential cancer drug
Submitted by
admin
on August 1, 2011 - 12:09pm
Source:
Bizjournals.com
News Tags:
Ariad Pharmaceuticals
EU
Merck
ridaforolimus
Headline:
ARIAD shares rise on EU review of potential cancer drug
Do Not Allow Advertisers to Use My Personal information
